vimarsana.com

Latest Breaking News On - Tumor microenvironment activated biologics - Page 1 : vimarsana.com

Short Interest in Sensei Biotherapeutics, Inc (NASDAQ:SNSE) Increases By 250 6%

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 282,600 shares, a growth of 250.6% from the May 15th total of 80,600 shares. Based on an average daily volume of 250,600 shares, the short-interest ratio […]

Sensei biotherapeuticsSensei biotherapeutics incSensei biotherapeutics company profileGet free reportTumor microenvironment activated biologics

Short Interest in Sensei Biotherapeutics, Inc (NASDAQ:SNSE) Increases By 250 6%

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 282,600 shares, a growth of 250.6% from the May 15th total of 80,600 shares. Based on an average daily volume of 250,600 shares, the short-interest ratio […]

Sensei biotherapeuticsSensei biotherapeutics incSensei biotherapeutics company profileGet free reportTumor microenvironment activated biologics

Sensei Biotherapeutics, Inc (NASDAQ:SNSE) Sees Significant Increase in Short Interest

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE – Get Free Report) saw a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 80,600 shares, a growth of 34.1% from the April 30th total of 60,100 shares. Currently, 0.5% of the company’s shares are sold short. Based on an […]

Sensei biotherapeuticsSensei biotherapeutics company profileSensei biotherapeutics incGet free reportTumor microenvironment activated biologics

Sensei Biotherapeutics (NASDAQ:SNSE) Receives Overweight Rating from Stephens

Stephens reiterated their overweight rating on shares of Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $5.00 price objective on the stock. Sensei Biotherapeutics Trading Down 45.5 % NASDAQ:SNSE opened at $0.79 on Friday. The company has a debt-to-equity ratio of […]

Sensei biotherapeuticsSensei biotherapeutics incFree reportGet free reportTumor microenvironment activated biologics

Sensei Biotherapeutics (NASDAQ:SNSE) Given Buy Rating at HC Wainwright

Sensei Biotherapeutics (NASDAQ:SNSE) Given Buy Rating at HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Sensei biotherapeuticsSensei biotherapeutics company profileSensei biotherapeutics incFree reportGet free reportTumor microenvironment activated biologics

vimarsana © 2020. All Rights Reserved.